Our Doctor is available for consultations by appointment and can be made by contacting the support team. Our consultation, advice and support is 100% obligation free. All of our Peptides are prescribed by experienced Anti Ageing Doctors. They are then compounded at one of our Australian pharmacies and then shipped Australia wide to Brisbane, Sydney, Melbourne, Hobart, Adelaide, Darwin, Perth and all regional areas.
A large difference between steroid hormones and peptide hormones is that some steroid hormones exhibit oral activity, in that they can be active after they are taken by mouth. However, many peptide hormones are digested in the same way as proteins. They are broken down into amino acids in the digestive system, which means they no longer have the bioactivity of their parent compound. Consequently, they may require administration through injections.
Results Mean gross morphological and histopathological scores were significantly higher in Group 1 than in Groups 2, 3, and 4, and the scores were significantly lower in Group 4 than in Groups 2 and 3. The lameness period in Group 4 was significantly shorter than those in Groups 1, 2, and 3. The lameness period in Group 1 was significantly longer than those in Groups 2 and 3. Conclusion: Intra-articular AOD9604 injections using ultrasound guidance enhanced cartilage regeneration, and combined AOD9604 and HA injections were more effective than HA or AOD9604 injections alone in the collagenase-induced knee OA rabbit model.
HUMAN GH (hGH) has profound lipolytic/antilipogenic actions in vivo, which result in decreased fat mass, increased lean mass, and weight loss (1–3). Studies in vitro and in vivo have indicated that this response is mediated in part by an increase inβ -adrenoceptor coupling efficiency (4), a reduction in Gi expression (5), increased activity of hormone sensitive lipase (6), and an inhibitory effect on the action of insulin (7). We have synthesized a fragment of hGH (AOD9604) that contains a lipolytic domain that may be responsible for the lipolytic action of hGH. The parent molecule, AOD9401, induces lipolysis and antilipogenesis and fat oxidation in adipose tissue in vitro (8, 9). In vivo, AOD9401 induces weight loss without affecting food intake as well as increasing lipolytic sensitivity and increasing fat oxidation with no adverse effects on insulin sensitivity (8, 10).
SARMs are selective androgen receptor modulators. Androgens are naturally occurring hormones—such as testosterone—that regulate the development and maintenance of male sex characteristics. SARMs provide the benefits of anabolic steroids (i.e., increased muscle mass/strength, fat loss, increased bone density, increased libido) without the quantity and/or severity of unwanted effects. SARMs are not toxic to the liver, separating them from most oral steroids and making them an attractive treatment option to those looking to benefit from anabolic steroid drugs.
I was keen to try out CJC 1295 because my gym buddies had been using it for a while with fast and positive results. Though I was a bit nervous about injecting myself! To my surprise, it was easier than I expected. So I ordered online with Peptides Clinics and received a fast and efficient service. Everything came packaged in ice packs and with relevant info. Initially, I tried with the lowest dosage of CJC-1295 which was 10 mg for 10 weeks. It wasn’t look before I was seeing results. In fact, I noticed pretty quickly an increase in lean muscle, and couldn’t believe the amount of weight I lost! Brilliant! But, I have been advised to try out the CJC 1295 Ipamorelin combination, which I will do soon!
All studies were performed according the Declaration of Helsinki (as amended in Edinburgh, Scotland, October 2000) and the ICH Guidelines for Good Clinical Practice (GCP) (E6). Further, independent ethics review committees of up to 16 Australian hospitals and medical centers have approved each of them. The two largest studies (METAOD005 and METAOD006) were registered at the Therapeutic Goods Administration’s Clinical Trial Notification (CTN) Scheme in Australia.
Prof. Louis J Aronne MD, President of the North American Association for the Study of Obesity and a member of Metabolic’s Clinical Advisory Panel, said: "This is an exciting new approach to a problem which has defied easy solutions. We will need many different treatments if we are going to manage obesity successfully, in much the same way we have many treatments available for diabetes and hypertension".
The ACMS recommended that Growth Hormone Releasing Hormones (GHRHs), Growth Hormone Secretagogues (GHSs), Growth Hormone Releasing Peptides (GHRPs) as well as new individual substance entries for CJC-1295, ipamorelin, pralmorelin (Growth Hormone Releasing Peptide-2), Growth Hormone Releasing Peptide-6, hexarelin and AOD-9604 be included in Schedule 4.
Steve Coggan, Chatswood, Sydney, “I am 48 and been weightlifting for 20 years. I have used CJC 1295 and Ipamorelin on their own and together, and have to say that when combining them they work better and faster. I have been using them for the past year, with 2 rest times. The combination of CJC 1295 Ipamorelin, is proving fantastic all round. Not only am I increasing muscle, my weight is down, but my skin is looking great. Some of the bags under my eyes have more or less gone. My missus thinks I look 10 years younger! Also, it has helped in the recovery of an injury to my knee after a fall. I have to say it isn’t cheap, but the results are worth it. CJC 1295 Ipamorelin side effects were few, just some headaches at first. You need to use it with a good diet and fitness regime for best results. I will definitely be continuing with it!”
The scheduling of paracetamol and caffeine when combined in a compound analgesic as the only two active ingredients was amended from Schedule 4 to Schedule 2 by the NDPSC at its 50th Meeting in June 2007. Evidence reviewed by the Committee at that time conclusively demonstrated that the key ingredient in terms of analgesic overuse and nephropathy was phenacetin and not caffeine. It was agreed that the indications for use, safety profile and potential for misuse met the criteria for a Schedule 2 medicine.
To really test the health benefits of drinking collagen peptides, I vowed to take it every day for two weeks. I opted for Vital Proteins Unflavored Grass-Fed Collagen Peptides in the blue tub. I got the 20-ounce tub and a box of the stick packs, which were perfect for when I went out of town. I stuck with one scoop from the tub for 35 calories, 9 grams of protein, and 10 grams of collagen (this was the same serving size in the stick packs).
The matters under subsection 52E (1) of the Therapeutic Goods Act 1989 considered relevant by the delegate included: a) the risks and benefits of the use of a substance; b) the purposes for which a substance is to be used and the extent of use of a substance; c) the toxicity of a substance; d) the dosage, formulation, labelling, packaging and presentation of a substance; e) the potential for abuse of a substance; f) any other matters that the Secretary considers necessary to protect the public health.
A NOTE ABOUT RELEVANT ADVERTISING: We collect information about the content (including ads) you use across this site and use it to make both advertising and content more relevant to you on our network and other sites. This is also known as Online Behavioural Advertising. You can find out more about our policy and your choices, including how to opt-out here.
The particle size of a drug molecule is a crucial factor in the effects of intra-articular injections. The larger the particle size, the longer the drug will stay in a joint, thereby increasing its efficacy . The short residence time of intra-articular AOD9604 when dissolved in saline was due to its rapid uptake by local circulation. However, the combination of AOD9604 with HA may result in more residence time and better effects in the joint. Recent studies [21–23] have shown that the addition of HA to nanoparticles improves the drug effects by increasing drug bioavailability and decreasing systemic absorption after topical administration.
The DAC technology in the CJC-1295 enables the compound to bind itself covalently with any circulating albumin, after it has been administered through a subcutaneous injection. However, the reason why the half-life could be extended from a few minutes to several days is more profound. The reactive group in the CJC-1295 binds to a peptide through bioconjugation. The peptide then finds a neucleophilic unit within the blood and reacts with it in order to create a firmer bond.
CJC1295: A growth hormone-releasing peptide, CJC1295 was first made by a Canadian biotechnology company to reduce fat deposits in obese AIDS patients. Research has shown that almost 100% of people injected with CJC1295 experienced side effects such as high blood pressure, diarrhoea, and headaches. There is no published evidence that CJC1295 produces any benefit to athletes. There is little or no peer-reviewed evidence that CJC1295 gives any advantage in sports, and as a growth hormone-releasing substance, is banned by WADA.
In vitro studies by Metabolic Collaborators showed that AOD9604 enhances the differentiation of adipose mesenchymal stem cells into bone, promotes proteoglycan and collagen production in isolated bovine chondrocytes, and promotes differentiation of myoblasts into C2C12 cells. These effects induced by AOD9604 are similar to those required for the repair of bone, cartilage, and muscle, all of which are affected in OA. To the best of our knowledge, no study has compared the effects of GH and HA intra-articular injections on OA. A previous study showed the effects of intra-articular GH injection on articulophyseal cartilage regeneration in the knees of rabbits . Our study showed that the groups that received AOD9604 or HA injection had better outcomes in terms of morphological and histolopathological findings, as well as a lowered duration of lameness than the group that received saline injections, although there are no significant differences between the two groups. In addition, our study revealed that the groups that received combined injections of AOD9604 and HA showed better outcomes than the groups that received AOD9604 or HA alone. The apparently synergistic effect of combined injections is thought to indicate that intra-articular injection of HA may have a chondrocyte-protective role, and the AOD9604 could help recapitulate the developmental cascades which regrows a segment of the articular cartilage in a joint. Our results are consistent with those of a previous study  that combined the injection of HA with recombinant human GH and found that the combination is more effective than HA injection alone.
IGF-1 is so named because of its close resemblance to insulin. Because IGF-1 is so similar to insulin, it interacts with insulin receptors on the surface of your cells, produces some of the same effects as insulin and even magnifies the effect of insulin. For example, one primary effect of both excess insulin and excess IGF-1 is hypoglycemia (low blood glucose). When you workout for a long time (longer than about one hour) your liver increases its release of IGF-binding protein (IGFBP-3) to prevent the onset of hypoglycemia that would otherwise happen as a result of the increased release of IGF-1 that occurs during training.
Obviously the longer you diet the more fat loss you can achieve. I always say people shouldn't expect results in a short time (obviously). But being blunt the results I observed with Bane were super fast. I could see the difference in his appearance in 2 days. I saw big changes in a few weeks so I would say it is possible. I imagine if it were used for 4 weeks with a strict diet amazing results could be made. It all depends upon the research subjects response, diet etc. Let me know what you decide to do and how you find it.
For example, there are Growth Hormone Releasing Peptides (GHRP’s with names such as ipamorelin and hexarein) which allow for a slow and steady growth hormone release that produces a pulse which mimics natural growth hormone release times and Growth Hormone Releasing Hormones (GHRH’s such as Mod-GRF) for an even stronger natural release of growth hormone and greater presence of growth hormone precursors known as GH “frags” or fragments.
Among peptide hormones are a group of substances that are capable of increasing the release of growth hormone. One such hormone is have developed synthetic peptide hormones, known as secretagogues, that also stimulate the release of hGH. These include substances such as GHRP6 and CJC-1295 which will be covered in greater detail elsewhere.growth hormone releasing hormone (GHRH). This is a hormone that is produced in the hypothalamus of the brain. This hormone binds to the growth hormone releasing hormone receptor to stimulate the release of growth hormone. Over recent years, pharmaceutical companies
The effect of AOD9604 and hGH on β3-ARs in adipose tissue is believed to be a direct action of these compounds and not an effect secondary to the fat metabolism, given that both AOD9604 and hGH can influence β3-AR expression and function in a nonadipocyte human cell line (11). Hence, the β3-AR appears to be necessary for the chronic effectiveness of AOD9604 on lipolysis in BAT.
This is cutting edge science and i freely admit is a PE...you could argue whey, bcaa or even intermittent fasting does the same thing, just not as refined hence the argument and confusion is that the substance is grey because the peptide stimulates natural GH which not even wada or asada know how to pidgeon hole it....its mostly unclassified...this is why we will be just fine... are you starting to see the glaring holes in your facts yet?
In this paper, we investigated whether the changes observed inβ 3-AR RNA expression in vitro also occur in an in vivo model. The in vivo model used was the obese (ob/ob) mouse model of obesity that has repressed levels of β3-ARs, which in part contributes to reduced lipolytic sensitivity (12). Lean C57BL/6J mice were used as a control. Following a 14-d chronic administration with AOD9604 or hGH, adipose tissue weights were measured, and β3-AR mRNA expression was determined. The decrease in weight of adipose tissue depots in the ob/ob mice was associated with increasedβ 3-AR expression. Further studies inβ 3-AR knock-out (β3-KO) mice showed that the presence of the β3-AR is necessary to mediate the chronic effectiveness of hGH and AOD9604 with regards to weight loss and fat mass reduction. However, an acute dose of AOD9604 was capable of increasing energy expenditure inβ 3-KO mice, although the response was less than that seen in the wild-type control mice.
DX-7 pushes the boundaries of fast acting diet pills! This formula is designed as a powerful detox with a 7 day formula! As one of the most effective short term detox diet pills on the market, DX-7 helps those who may have put on a few winter pounds. With powerful detox ingredients, this formula will help those that are trying to kick off a new year’s goals or trying to reach specific weight loss goals with an extra kick!
Paracetamol/caffeine formulations have a long-established safety and efficacy profile over 25 years of use as an open-sale medicine in major markets around the world. The paracetamol/caffeine combination analgesic was registered as a schedule 2 product in Australia and has been marketed since 2010. Since that time no new significant issues or potential risks have been reported.
23 Pivovarova O, Gogebakan O, Kloting N, Sparwasser A, Weickert MO, Haddad I, Nikiforova VJ, Bergmann A, Kruse M, Seltmann AC, Bluher M, Pfeiffer AF, Rudovich N. Insulin up‐regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?J Clin Endocrinol Metab. 2012;97:E731–E739.CrossrefMedlineGoogle Scholar
For example, if 100mcg more were to be administered after the first 100mcg (making the effective dose of 200mcg), then the second dose will achieve only 50% of what the first dose already did. A 100mcg more (making a total of 300mcg) will achieve only 25% more of the initial dose. This implies that, in order to increase the effect of the compound, only a little more of it can be successfully administered after the saturation dose.
Various experiments have been conducted to test the effectiveness of CJC 1295-DAC in vivo and the Journal of Clinical Endocrinology & Metabolism has reported dose-dependent increases in mean plasma GH concentrations by 2-10 fold for more than 6 days and increased IGF-1 concentrations 1.5-3 fold for 9-11 days after a single injection. Mean half-life was shown to be 5.8-8.1 days, also after multiple doses mean IGF-1 levels remained above baseline for up to 28 days. No serious adverse reactions were reported in any group.
The test substance was either administered intravenously (studies METAOD001 and METAOD002) or as a capsule/tablet. The hexadecapeptide AOD9604 was produced under cGMP conditions by PolyPeptide Laboratories (Torrance, CA, USA). For studies 1 and 2, the product was supplied in a lyophilized form and reconstituted before usage with the designated volume of sterile water for intravenous injection. The capsules/tablets were manufactured using a common excipient mix (Capsules: Mannitol, PEG3350 (in studies METAOD003, METAOD004 and METAOD005)); or Tablets: L-Arginine Free Base, Microcrystalline Cellulose, Fumed silica, Magnesium Stearate (in study METAOD006)).
Gamma-Oryzanol (γ-Oryzanol): An antioxidant extracted from rice bran oil, wheat bran and some fruits and vegetables, γ-Oryzanol has been used as an alternative medicine in the treatment of high cholesterol, symptoms of menopause and ageing, mild anxiety and stomach upsets. Although it is used in sports to apparently increase testosterone and growth hormone levels, as well as improving strength during resistance exercise training, there is not enough evidence to determine its effect on hormone levels in humans. Even though animal studies suggest that γ-Oryzanol might actually reduce testosterone production, it has been marketed to, and used by, body builders and strength-training athletes in the hope of boosting strength, increasing muscle gain, reducing body fat, speeding recovery and reducing post-exercise soreness. γ-Oryzanol is not banned by WADA.
The biggest negative, and this is a big one, is that AOD9604 has undergone very rigorous scientific testing, and has been found to have no effect in humans (3). When AOD9604 was first developed, it showed significant promise as a weight loss treatment. A special strain of obese mice supplemented with the peptide showed a reduction in weight, increased fat oxidation, and raised plasma glycerol, which are indicators of lipolysis, or fat burning (5). Subsequent studies in obese mice and rats attempted to show that the peptide works to burn fat in the same way as human growth hormone, but found that this was not the case, meaning that the fact this peptide resembled hGH was meaningless. Scientists were unable to determine how this peptide was working in mice (6).
But ever since the 1970’s, scientists have observed that although we produce substantial amounts of both IGF-1 and human growth hormone (HGH) in childhood, these hormones decrease drastically by the time we reach old age. They also noticed that IGF-1 could possibly be manipulated to extend life and to prolong the deteriorating effects of aging (you can read the research here).